Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 4/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170617 | 0.90 | OPRM1 (0.38) | OPRM1OPRD1OPRK1TSHR | |
| SCHEMBL31711370 | 0.87 | OPRM1 (0.37) | OPRM1OPRD1OPRK1TSHR | |
| Ammonia Solution, Strong SCHEMBL4662387 | 0.87 | OPRM1 (0.37) | OPRM1OPRD1OPRK1TSHR | |
| Hydrochloric Acid SCHEMBL1234433 | 0.87 | OPRM1 (0.40) | OPRM1OPRD1OPRK1TSHR | |
| SCHEMBL20835283 | 0.85 | OPRM1 (0.36) | OPRM1OPRD1OPRK1TSHR | |
| Hydroxyamine SCHEMBL27747249 | 0.85 | OPRM1 (0.36) | OPRM1OPRD1OPRK1TSHR | |
| SCHEMBL147493 | 0.85 | TSHR (0.37) | OPRM1OPRD1OPRK1TSHR | |
| Trolamine SCHEMBL9856574 | 0.82 | TSHR (0.35) | OPRM1OPRD1OPRK1TSHR | |
| Hydrochloric Acid SCHEMBL7722967 | 0.82 | OPRK1 (0.36) | OPRM1OPRD1OPRK1TSHR | |
| Bromide SCHEMBL11042426 | 0.82 | KDM4E (0.35) | OPRM1OPRD1OPRK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 919 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | SYMRISE AG (DE) | 2024-07-02 | — | — | US | claimed |
| US-8741961-B2 | Use of pargyline for the treatment of hair follicles | CUTECH S.R.L. (IT) | 2014-06-03 | — | — | US | claimed |
| US-20240240106-A1 | 1,4-BUTANEDIOL MONO- OR DIESTERS FOR USE AS AROMA CHEMICALS | BASF SE (DE) | 2024-07-18 | — | — | US | disclosed |
| EP-3532018-B1 | USE OF 1-[(4R)-4-METHYLCYCLOHEXEN-1-YL]ETHANONE AS AN AROMA CHEMICAL | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-20240225975-A9 | AN IMPROVED LONG WEARING SUNSCREEN COSMETIC | BASF SE (DE) | 2024-07-11 | — | — | US | disclosed |
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | SYMRISE AG (DE) | 2024-07-02 | — | — | US | disclosed |
| EP-4387950-A1 | USE OF 1-(4- TERT- BUTYL CYCLOHEXYL) PROPYL ACETATE AS AROMA INGREDIENT | BASF SE (DE) | 2024-06-26 | — | — | EP | disclosed |
| US-12016944-B2 | Mixtures comprising a protein extract for the treatment of human skin and/or hair | SYMRISE AG (DE) | 2024-06-25 | — | — | US | disclosed |
| US-20240199520-A1 | 2-(2-(3-METHYLBUT-2-EN-1YL)PHENYL) PROPANAL AND MIXTURES THEREOF AS AROMA INGREDIENT | BASF SE (DE) | 2024-06-20 | — | — | US | disclosed |
| US-20240199516-A1 | DIALKYLPENTENE ETHER AND DIALKYLPENTADIENE ETHER DERIVATIVES AS FRAGRANCES | BASF SE (DE) | 2024-06-20 | — | — | US | disclosed |
| WO-2024126047-A1 | BLEACH POWDER AND METHOD FOR BLEACHING HAIR | WELLA GERMANY GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| US-6033652-A | SUGAR SURFACTANTS, SILICONE COMPOUNDS LIQUID AT ROOM TEMPERATURE AND LESS THAN 2% BY WEIGHT OF PEARLESCING WAXES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-03-07 | — | — | US | disclosed |
| US-5962663-A | PRODUCING BIOPOLYMER WITH HIGH MOLECULAR WEIGHT AND LOW VISCOSITY BY REPEATEDLY CONTACTING FRESH CRUSTACEAN SHELLS WITH AQUEOUS MINERAL ACID AND ALKALI METAL HYDROXIDE SOLUTIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1999-10-05 | — | — | US | disclosed |
| US-5939081-A | THICKENING AN OIL-IN-WATER EMULSION BY ADDING A THICKENING AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1999-08-17 | — | — | US | disclosed |
| US-5880299-A | REACTING TRIALKANOLAMINES WITH A MIXTURE OF FATTY ACIDS AND DICARBOXYLIC ACIDS AND QUATERNIZING THE RESULTING ESTER | HENKEL CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
| US-5811386-A | Clear surface-active mixtures containing anionic surfactant, APG, and temporarily cationic copolymer | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1998-09-22 | — | — | US | disclosed |
| US-5795978-A | CONTAINING ALKYL OR ALKENL OLIGOGLYCOSIDE AND FATTY ALCOHOL;COSMETICS, DRUGS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1998-08-18 | — | — | US | disclosed |
| US-5711899-A | ANIONIC, AMPHOTERIC AND/OR ZWITTERION SURFACTANTS WITH PEARLESCENT CONCENTRATES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1998-01-27 | — | — | US | disclosed |
| US-5631003-A | ZWITTERIONIC POLYMER AND 2-PYRROLIDONE DERIVATIVE, SHAMPOO AND CONDITIONERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-05-20 | — | — | US | disclosed |
| US-5291905-A | Hair treatment applicator | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1994-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12023396-B2 | Flavour and fragrance compositions comprising acetophenone derivatives | FAAH2, ADH5, NISCH | OPRM1 1414/4885OPRD1 616/4885OPRK1 1247/4885 |
| US-20240199520-A1 | 2-(2-(3-METHYLBUT-2-EN-1YL)PHENYL) PROPANAL AND MIXTURES THEREOF AS AROMA INGREDIENT | PIR, ENY2, IMPA1 | OPRM1 413/4885OPRD1 348/4885OPRK1 308/4885 |
| US-20240199516-A1 | DIALKYLPENTENE ETHER AND DIALKYLPENTADIENE ETHER DERIVATIVES AS FRAGRANCES | DEK, TRPA1, DGKI | OPRM1 443/4885OPRD1 191/4885OPRK1 150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.